Accord BioPharma's HERCESSI™ (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies

Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...

Accord BioPharma's HERCESSI(TM) (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies

HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...
casereports.bmj

Unilateral pulmonary hypoplasia: a rare clinical presentation

2 VCSG Government Medical Sciences and Research Institute, Srinagar (Garhwal), Uttarakhand, India The clinical presentation of an adolescent man with left lung hypoplasia is described in detail ...

Are severe lung conditions in newborns always fatal? Doctors weigh in, debunk myths and share case studies

Modern neonatal care offers significant hope for newborns with severe lung issues, debunking old myths of inevitable fatality. Experts emphasize that advanced treatments, including ventilation and ...
thorax.bmj

British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE

Correspondence to Professor David R Baldwin, Nottingham University Hospitals and University of Nottingham, Respiratory Medicine Unit, David Evans Research Centre, Nottingham University Hospitals, ...
BMJ

Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network ...

Persistent pulmonary hypertension of the newborn (PPHN) is the most common neonatal form and mostly reversible after a few days with improvement of the underlying pulmonary condition. When pulmonary ...